Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

GFAPδ/GFAPα ratio directs astrocytoma gene expression towards a more malignant profile.

Stassen OMJA, van Bodegraven EJ, Giuliani F, Moeton M, Kanski R, Sluijs JA, van Strien ME, Kamphuis W, Robe PAJ, Hol EM.

Oncotarget. 2017 Oct 4;8(50):88104-88121. doi: 10.18632/oncotarget.21540. eCollection 2017 Oct 20.

2.

RIZ1 negatively regulates ubiquitin-conjugating enzyme E2C/UbcH10 via targeting c-Myc in meningioma.

Cai Z, Zou Y, Hu H, Lu C, Sun W, Jiang L, Hu G.

Am J Transl Res. 2017 May 15;9(5):2645-2655. eCollection 2017.

3.

Metabotropic glutamate receptors as a new therapeutic target for malignant gliomas.

Pereira MSL, Klamt F, Thomé CC, Worm PV, de Oliveira DL.

Oncotarget. 2017 Mar 28;8(13):22279-22298. doi: 10.18632/oncotarget.15299. Review.

5.

Cooperative genomic alteration network reveals molecular classification across 12 major cancer types.

Zhang H, Deng Y, Zhang Y, Ping Y, Zhao H, Pang L, Zhang X, Wang L, Xu C, Xiao Y, Li X.

Nucleic Acids Res. 2017 Jan 25;45(2):567-582. doi: 10.1093/nar/gkw1087. Epub 2016 Nov 29.

6.

Computational approaches for the identification of cancer genes and pathways.

Dimitrakopoulos CM, Beerenwinkel N.

Wiley Interdiscip Rev Syst Biol Med. 2017 Jan;9(1). doi: 10.1002/wsbm.1364. Epub 2016 Nov 11. Review.

7.

The non-coding landscape of head and neck squamous cell carcinoma.

Zou AE, Zheng H, Saad MA, Rahimy M, Ku J, Kuo SZ, Honda TK, Wang-Rodriguez J, Xuan Y, Korrapati A, Yu V, Singh P, Grandis JR, King CC, Lippman SM, Wang XQ, Hinton A, Ongkeko WM.

Oncotarget. 2016 Aug 9;7(32):51211-51222. doi: 10.18632/oncotarget.9979.

8.

Quantitative proteomics reveals the novel co-expression signatures in early brain development for prognosis of glioblastoma multiforme.

Yu X, Feng L, Liu D, Zhang L, Wu B, Jiang W, Han Z, Cheng S.

Oncotarget. 2016 Mar 22;7(12):14161-71. doi: 10.18632/oncotarget.7416.

9.

Patient-Derived Xenografts as a Model System for Radiation Research.

Willey CD, Gilbert AN, Anderson JC, Gillespie GY.

Semin Radiat Oncol. 2015 Oct;25(4):273-80. doi: 10.1016/j.semradonc.2015.05.008. Epub 2015 May 14. Review.

10.

Magnetic resonance image features identify glioblastoma phenotypic subtypes with distinct molecular pathway activities.

Itakura H, Achrol AS, Mitchell LA, Loya JJ, Liu T, Westbroek EM, Feroze AH, Rodriguez S, Echegaray S, Azad TD, Yeom KW, Napel S, Rubin DL, Chang SD, Harsh GR 4th, Gevaert O.

Sci Transl Med. 2015 Sep 2;7(303):303ra138. doi: 10.1126/scitranslmed.aaa7582.

11.

Identification of Global DNA Methylation Signatures in Glioblastoma-Derived Cancer Stem Cells.

Lee EJ, Rath P, Liu J, Ryu D, Pei L, Noonepalle SK, Shull AY, Feng Q, Litofsky NS, Miller DC, Anthony DC, Kirk MD, Laterra J, Deng L, Xin HB, Wang X, Choi JH, Shi H.

J Genet Genomics. 2015 Jul 20;42(7):355-71. doi: 10.1016/j.jgg.2015.06.003. Epub 2015 Jun 24.

12.

Chromatin states modify network motifs contributing to cell-specific functions.

Zhao H, Liu T, Liu L, Zhang G, Pang L, Yu F, Fan H, Ping Y, Wang L, Xu C, Xiao Y, Li X.

Sci Rep. 2015 Jul 14;5:11938. doi: 10.1038/srep11938.

13.

Ubiquitin-protein ligase E3C promotes glioma progression by mediating the ubiquitination and degrading of Annexin A7.

Pan SJ, Zhan SK, Ji WZ, Pan YX, Liu W, Li DY, Huang P, Zhang XX, Cao CY, Zhang J, Bian LG, Sun B, Sun QF.

Sci Rep. 2015 Jun 11;5:11066. doi: 10.1038/srep11066.

14.

Gene Perturbation Atlas (GPA): a single-gene perturbation repository for characterizing functional mechanisms of coding and non-coding genes.

Xiao Y, Gong Y, Lv Y, Lan Y, Hu J, Li F, Xu J, Bai J, Deng Y, Liu L, Zhang G, Yu F, Li X.

Sci Rep. 2015 Jun 3;5:10889. doi: 10.1038/srep10889.

15.

Feedback circuitry between miR-218 repression and RTK activation in glioblastoma.

Mathew LK, Huangyang P, Mucaj V, Lee SS, Skuli N, Eisinger-Mathason TS, Biju K, Li B, Venneti S, Lal P, Lathia JD, Rich JN, Keith B, Simon MC.

Sci Signal. 2015 May 5;8(375):ra42. doi: 10.1126/scisignal.2005978.

16.

Advances and challenges in the molecular biology and treatment of glioblastoma-is there any hope for the future?

Veliz I, Loo Y, Castillo O, Karachaliou N, Nigro O, Rosell R.

Ann Transl Med. 2015 Jan;3(1):7. doi: 10.3978/j.issn.2305-5839.2014.10.06. Review.

17.

Targeting the adaptability of heterogeneous aneuploids.

Chen G, Mulla WA, Kucharavy A, Tsai HJ, Rubinstein B, Conkright J, McCroskey S, Bradford WD, Weems L, Haug JS, Seidel CW, Berman J, Li R.

Cell. 2015 Feb 12;160(4):771-84. doi: 10.1016/j.cell.2015.01.026.

18.

Identifying core gene modules in glioblastoma based on multilayer factor-mediated dysfunctional regulatory networks through integrating multi-dimensional genomic data.

Ping Y, Deng Y, Wang L, Zhang H, Zhang Y, Xu C, Zhao H, Fan H, Yu F, Xiao Y, Li X.

Nucleic Acids Res. 2015 Feb 27;43(4):1997-2007. doi: 10.1093/nar/gkv074. Epub 2015 Feb 4.

19.

The molecular pathogenesis of colorectal cancer and its potential application to colorectal cancer screening.

Grady WM, Markowitz SD.

Dig Dis Sci. 2015 Mar;60(3):762-72. doi: 10.1007/s10620-014-3444-4. Epub 2014 Dec 10. Review.

20.

Identification of a NFKBIA polymorphism associated with lower NFKBIA protein levels and poor survival outcomes in patients with glioblastoma multiforme.

Zhao Z, Zhong X, Wu T, Yang T, Chen G, Xie X, Wei Y, Ye M, Zhou Y, Du Z.

Int J Mol Med. 2014 Nov;34(5):1233-40. doi: 10.3892/ijmm.2014.1932. Epub 2014 Sep 12.

Supplemental Content

Support Center